Cumulative analysis of inhibitor formation in patients with haemophilia A treated with sucrose-formulated recombinant factor VIII.
Bajwa
N
N
Enriquez
M M
MM
Gorina
E
E
Lemm
G
G
D005169:Factor VIII / Q000627:therapeutic use*; D006467:Hemophilia A / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D013395:Sucrose / Q000627:therapeutic use*; D016896:Treatment Outcome
C438308:recombinant FVIII, sugar formulated; D013395:Sucrose; D005169:Factor VIII